This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 18 and 90
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

To evaluate the dynamic alterations of Th2/Th1 for the prediction of clinical immunity and how it was related to 28 day-prognosis and ICU-acquired infections among critically ill patients of community-acquired severe sepsis with new onset.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02883218. The sponsor of the trial is Jianfeng Xie and it is looking for 85 volunteers for the current phase.
Official trial title:
Dynamic Alterations of Th2/Th1 With New Onset of Community-acquired Severe Sepsis